Clostridium Difficile Colitis (see Clostridium Difficile, [[Clostridium Difficile]])
Diarrhea (see Diarrhea, [[Diarrhea]]): occurs in 4.4% of cases
Elevated Liver Function Tests (LFT’s) (see xxxx, [[xxxx]]): elevated ALT
Nausea (see Nausea and Vomiting, [[Nausea and Vomiting]]): occurs in 5% of cases
Neurologic Adverse Effects
Headache (see Headache, [[Headache]]): occurs in 4.7% of cases
Other Adverse Effects
xxx
xxx
xxx
References
Dalvance® (dalbavancin) for injection Full Prescribing Information. Chicago, IL: Durata Therapeutics, Inc. 2014
Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med. 2014;370:2169-2179
Economic burden of hospitalization with antibiotic treatment for ABSSSI in the United States: an analysis of the Premier Hospital Database. Presented at ISPOR 2012. Washington, D.C. June 2-6, 2012. (Poster PIN22)